Cepravin Dry Cow 250 mg, suspension intramammaire
Cepravin Dry Cow 250 mg, suspension intramammaire
Authorised
- Cefalonium dihydrate
Product identification
Medicine name:
Cepravin Dry Cow 250 mg, suspension intramammaire
Cepravin Dry Cow 250 mg Suspension zur intramammären Anwendung
Active substance:
- Cefalonium dihydrate
Target species:
-
Cattle (dairy cattle)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefalonium dihydrate250.00/milligram(s)3.00gram(s)
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dairy cattle)
-
Milkno withdrawal periodIf calving occurs after 54 days after treatment, milk for human consumption may only be taken 96 hours. If calving occurs before 54 days after treatment, milk for human consumption may be taken after 54 days plus 96 hours after treatment.
-
Meat and offalno withdrawal period0 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- 20 x 3 g Intramammary syringe
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International GmbH
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 817/86/07/0355
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 10/08/2023
Updated on: 11/08/2023
